Current Clinical Trials

• A Phase III, Multi-Center Randomized Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment with CGT003 of Coronary Vein Grafts in Patients Indergoing CABG Procedures (Corgentech)
• A Pilot, Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate Nesiritide Infusion, Initiated Post-Inductin of Anesthesia, in the Management of CABG Patients (Scios).
• Surgical Treatment for Ischemic Heart (Stitch) Failure Trial (DCRI).
• Clinical Evaluation of the Shellhigh Stentless Porcine Bioprostheses for Aortic Valve Replacement Model NR-2000 Plus and Model NR-2000 Plus No-React treated.
• A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study of 2 mg/kg Bolus Plus 24-hour 0.05 mg/kg/hr infusion of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass (PRIMO-CABG II).
• A prospective, non-randomized, evaluation of the CorLink distal automated anastomotic system for left internal thoracic artery to left anterior descending artery grafts during coronary bypass surgery.
• Correlation of vessel measurements made with vessel sizers to suitability of the vessel for inserter application and vessel wall mechanics with the CorLink AAD.
• A randomized, multi-center trial comparing outcomes with destination therapy for patients with end-stage heart failure requiring circulatory support using the Novacor or HeartMate implantable left ventricular assist devices (RELIANT).